ConvaTec Group PLC
SWB:2CV

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
SWB:2CV
Watchlist
Price: 2.68 EUR Market Closed
Market Cap: €3.6B

Net Margin

12.4%
Current
Improving
by 4.5%
vs 3-y average of 7.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.4%
=
Net Income
$216.7m
/
Revenue
$2.4B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
12.4%
=
Net Income
€216.7m
/
Revenue
$2.4B

Peer Comparison

Country Company Market Cap Net
Margin
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP
Loading...
JP
Hoya Corp
TSE:7741
8.8T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.9B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.5B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
122.3B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.7B USD
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.2B CNY
Loading...
KR
HLB Inc
KOSDAQ:028300
7.3T KRW
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF
Loading...
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD
Loading...

Market Distribution

Higher than 97% of companies in United Kingdom
Percentile
97th
Based on 3 670 companies
97th percentile
12.4%
Low
-188 120% — 0%
Typical Range
0% — 0.1%
High
0.1% — 10 443.9%
Distribution Statistics
United Kingdom
Min -188 120%
30th Percentile 0%
Median 0%
70th Percentile 0.1%
Max 10 443.9%

ConvaTec Group PLC
Glance View

Market Cap
3.6B EUR
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

2CV Intrinsic Value
3.38 EUR
Undervaluation 21%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
12.4%
=
Net Income
$216.7m
/
Revenue
$2.4B
What is ConvaTec Group PLC's current Net Margin?

The current Net Margin for ConvaTec Group PLC is 12.4%, which is above its 3-year median of 7.9%.

How has Net Margin changed over time?

Over the last 3 years, ConvaTec Group PLC’s Net Margin has increased from 4.7% to 12.4%. During this period, it reached a low of 3.7% on Dec 31, 2022 and a high of 12.6% on Jun 30, 2025.

Back to Top